Nichi-Iko's gross profit FY 2013-2022
In fiscal year 2022, the gross profit of Nichi-Iko Pharmaceutical Co.,Ltd. decreased to the lowest point of the past decade of approximately four billion Japanese yen. Headquartered in Toyama Prefecture, Nichi-iko is a leading generic drug manufacturer in Japan in terms of sales.